Cargando…

Continuous Cardiac Troponin I Release in Fabry Disease

BACKGROUND: Fabry disease (FD) is a rare lysosomal storage disorder also affecting the heart. The aims of this study were to determine the frequency of cardiac troponin I (cTNI) elevation, a sensitive parameter reflecting myocardial damage, in a smaller cohort of FD-patients, and to analyze whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feustel, Andreas, Hahn, Andreas, Schneider, Christian, Sieweke, Nicole, Franzen, Wolfgang, Gündüz, Dursun, Rolfs, Arndt, Tanislav, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953535/ https://www.ncbi.nlm.nih.gov/pubmed/24626231 http://dx.doi.org/10.1371/journal.pone.0091757

Ejemplares similares

Persistent increase in cardiac troponin I in Fabry disease: a case report
por: Tanislav, Christian, et al.
Publicado: (2011)

Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease
por: Tanislav, Christian, et al.
Publicado: (2016)

Cardiac Troponin I elevation after epileptic seizure
por: Sieweke, Nicole, et al.
Publicado: (2012)

Fabry Disease – Underestimated in the Differential Diagnosis of Multiple Sclerosis?
por: Böttcher, Tobias, et al.
Publicado: (2013)

How is cardiac troponin released from cardiomyocytes?( )
por: Hammarsten, Ola, et al.
Publicado: (2022)

cAMP controls the restoration of endothelial barrier function after thrombin‐induced hyperpermeability via Rac1 activation
por: Aslam, Muhammad, et al.
Publicado: (2014)

Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation
por: Gündüz, Dursun, et al.
Publicado: (2019)

High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
por: Seydelmann, Nora, et al.
Publicado: (2016)

Value of Left Ventricular Feature Tracking Strain Analysis for Detection of Early Cardiac Involvement in Fabry Disease (FD)
por: Roller, Fritz Christian, et al.
Publicado: (2021)

Inhibition of Protein Prenylation of GTPases Alters Endothelial Barrier Function
por: Aslam, Muhammad, et al.
Publicado: (2019)

Cerebral vein thrombosis: clinical manifestation and diagnosis
por: Tanislav, Christian, et al.
Publicado: (2011)

Idiopathic Small Fiber Neuropathy: Phenotype, Etiologies, and the Search for Fabry Disease
por: Samuelsson, Kristin, et al.
Publicado: (2014)

The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients
por: Hammarsten, Ola, et al.
Publicado: (2022)

Cardiac troponin T and I: back to basics
por: Mingels, Alma M, et al.
Publicado: (2023)

Baseline characteristics in stroke patients with atrial fibrillation: clinical trials versus clinical practice
por: Tanislav, Christian, et al.
Publicado: (2015)

Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study
por: Tanislav, Christian, et al.
Publicado: (2011)

Cardiac Troponin I autoantibodies and their potential role in cardiac remodelling
por: Salbach, Christian, et al.
Publicado: (2019)

Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease
por: Lukas, Jan, et al.
Publicado: (2020)

Uridine Triphosphate Thio Analogues Inhibit Platelet P2Y(12) Receptor and Aggregation
por: Gündüz, Dursun, et al.
Publicado: (2017)

Effect of Exercise Intensity and Duration on Cardiac Troponin Release
por: Marshall, Lucy, et al.
Publicado: (2020)

How to use cardiac troponin in non-cardiac surgery
por: Puelacher, Christian, et al.
Publicado: (2023)

Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation
por: Hessel, M. H. M., et al.
Publicado: (2007)

Diagnosing moyamoya syndrome using ultrasound - a case report
por: Braun, Tobias, et al.
Publicado: (2015)

Dephosphorylation specificities of protein phosphatase for cardiac troponin I, troponin T, and sites within troponin T
por: Jideama, Nathan M., et al.
Publicado: (2006)

Genotype–Phenotype Correlation in a New Fabry-Disease-Causing Mutation
por: Čerkauskaitė, Agnė, et al.
Publicado: (2019)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

The Metabolic Pathway of Cardiac Troponins Release: Mechanisms and Diagnostic Role
por: Chaulin, Aleksey Michailovich
Publicado: (2022)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice
por: Tanislav, Christian, et al.
Publicado: (2014)

Cardiac Troponin I as Compared to Troponin T for the Detection of Myocardial Damage in Horses
por: Van Der Vekens, N., et al.
Publicado: (2015)

Relationship between cardiac troponin I (cTnI) release during cardiac operations and myocardial cell death
por: Vazquez-Jimenez, JF, et al.
Publicado: (2000)

High‐Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease
Publicado: (2016)

Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
por: Lukas, Jan, et al.
Publicado: (2013)

Cardiac Troponin Release After Endurance Exercise: Still Much to Learn
por: Airaksinen, K. E. Juhani
Publicado: (2020)

Cardiac Troponin T Release after Football 7 in Healthy Children and Adults
por: Cirer-Sastre, Rafel, et al.
Publicado: (2020)

Exercise-Induced Release of Cardiac Troponins in Adolescent vs. Adult Swimmers
por: Cirer-Sastre, Rafel, et al.
Publicado: (2021)

Chemiluminescence Biosensor for the Determination of Cardiac Troponin I (cTnI)
por: Tannenberg, Robert, et al.
Publicado: (2023)

Exercise‐induced release of troponin
por: Stavroulakis, George A., et al.
Publicado: (2020)

Inconsistent Findings of Cardiac Troponin T and I in Clinical Routine Diagnostics: Factors of Influence
por: Eidizadeh, Abass, et al.
Publicado: (2021)

Clinical signs in young patients with stroke related to FAST: results of the sifap1 study
por: Kaps, Manfred, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l86h8mh8vedgqav0gjsbi6c55h